Will we learn anything?

Will we learn anything?

Here we are with yet another EASD which basically means there will lots of news this week. The question is will we learn anything from all this news. Sadly I believe the answer is no. The real problem is our wacky world hasn’t gotten the memo yet. Here’s the problem in a nutshell this week you’ll see lots of data about the toys in the toy chest and drugs in the medicine cabinet. Already we have seen reports extolling the virtues of CGM technology and GLP1 therapy.

What you won’t see is companies adapting to the . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.